Future unrelated medical costs need to be considered in cost effectiveness analysis

5 March 2019 - New medical technologies that prolong life result in additional health care use in life years gained. Some ...

Read more →

Analysis of base-case ICERs accepted by the PBAC (July 2018)

30 October 2018 - There appear to be one or two examples where the PBAC accepted a higher than usual ...

Read more →

What is the evidence from past NICE single-technology appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY?

22 March 2018 - NICE has recently proposed that company submissions with a base-case incremental cost-effectiveness ratio of less than ...

Read more →

Estimating a cost-effectiveness threshold for the Spanish NHS

28 December 2017 - The cost of generating a quality-adjusted life year within a National Health Service provides an approximation of ...

Read more →

Unrelated future costs and unrelated future benefits: reflections on NICE Guide to the Methods of Technology Appraisal

3 July 2016 - This editorial considers the vexing issue of ‘unrelated future costs’ (for example, the costs of caring ...

Read more →

Changes to number of copies of the economic model and category 1 requirements to be filed with CADTH

2 November 2015 - Going forward, CADTH has revised the number of copies of the economic model to be provided at ...

Read more →